|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Foamix Pharmaceuticals Ltd (FOMX) |
|
|
$3.24 0.00 (0.00%) as of 4:30 Thu 3/5
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
36,600,000 |
| Market
Cap: |
118.58(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.24 - $3.24 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Elliott Russell P. |
VP Drug Development |
• – – |
2018-01-02 |
4 |
D |
$5.98 |
$3,319 |
D/D |
(555) |
4,935 |
|
- |
|
| Eini Meir |
Observer to the Board |
– – – |
2018-01-02 |
4 |
AS |
$6.18 |
$30,903 |
I/I |
(5,000) |
2,752,781 |
|
- |
|
| Schuz David |
VP IP |
• – – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,745 |
19,980 |
|
- |
|
| Shirvan Mitchell |
VP Innovation & Discovery |
• – – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,745 |
19,980 |
|
- |
|
| Howard Alvin D |
VP Regulatory |
• – – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,288 |
35,915 |
|
- |
|
| Domzalski David |
CEO |
• • – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,948 |
142,819 |
|
- |
|
| Elliott Russell P. |
VP Drug Development |
• – – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,372 |
5,490 |
|
- |
|
| Hazot Yohan |
VP Pharmaceutical Development |
• – – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,575 |
27,300 |
|
- |
|
| Hadar Ilan |
CFO & Country Manager |
• – – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,032 |
80,681 |
|
- |
|
| Eini Meir |
Observer to the Board |
– – – |
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,032 |
16,271 |
|
- |
|
| Kroin David |
10% Owner |
– – • |
2017-04-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,781,708 |
|
- |
|
111 Records found
|
|
Page 5 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
